Infectious Diseases

sec_arr References
SECTIONS

References

  1. Jessop AB, Del Buono F, Solomon G, Mullen-Fortino M, Rogers JM. Police exposure to infectious agents: an audit of protective policies. Occup Med (Lond). 2014;64:546-548.
  2. Radin JM, Hawksworth AW, Blair PJ, et al. Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis. 2014;59:962-968.
  3. Heyman D, ed. Control of Communicable Diseases Manual. Washington, DC: American Public Health Association; 2008.
  4. Schlossberg D, ed. Clinical Infectious Disease. New York, NY: Cambridge University Press; 2008.
  5. Henderson DK, Dembry LM, Sifri CD, et al. Management of healthcare personnel living with hepatitis B, hepatitis C, or human immunodeficiency virus in US healthcare institutions. Infect Control Hosp Epidemiol. 2022;43:147-155.
  6. Moorman AC, de Perio MA, Goldschmidt R, et al. Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus – CDC Guidance, United States, 2020. MMWR Recomm Rep. 2020;69:1-8.
  7. Gutierrez JA, Lawitz EJ, Poordad F. Interferon-free, direct-acting antiviral therapy for chronic hepatitis C. J Viral Hepat. 2015;22:861-870.
  8. Beck A, Steer R, Brown GK. Beck Depression Inventory, Second Edition (BDI-II). San Antonio, TX: Pearson Education, Inc.; 1996.
  9. National Institute for Mental Health. Center for Epidemiologic Studies Depression Scale (CES-D). Available at: www.bcbsm.com/pdf/Depression_CES-D.pdf. Accessed June 3, 2011.
  10. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Measure. 1977;1:385-401.
  11. Clifford DB. HIV-associated neurocognitive disorder. Curr Opin Infect Dis. 2017;30:117-122.
  12. Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19:152-168.
  13. Joska JA WJ, Thomas KG, et al. A comparison of five brief screening tools for HIV-associated neurocognitive disorders in the USA and South Africa. AIDS Behav. 2016;20:1621-1631.
  14. Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:273-278.
  15. Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367-1374.
  16. Foreman BH, Mackler L, Malloy ED. Clinical inquiries. Can we prevent splenic rupture for patients with infectious mononucleosis? J Fam Pract. 2005;54:547-548.
  17. Grindel S, Shea M. Infections in athletes. In: Mellion MB, Putukian M, Madden C, eds. Sports Medicine Secrets, 3rd ed. Philadelphia, PA: Hanley & Belfus; 2003:207.
  18. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38:1407-1410.
  19. Cabellos C, Verdaguer R, Olmo M, et al. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine (Baltimore). 2009;88:115-119.
  20. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317-328.
  21. Rosman NP, Peterson DB, Kaye EM, Colton T. Seizures in bacterial meningitis: prevalence, patterns, pathogenesis, and prognosis. Pediatr Neurol. 1985;1:278-285.
  22. Wang KW, Chang WN, Chang HW, et al. The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis. Seizure. 2005;14:586-592.
  23. Zoons E, Weisfelt M, de Gans J, et al. Seizures in adults with bacterial meningitis. Neurology. 2008;70:2109-2115.
  24. Materna B, Harriman K, Rosenberg J, et al. Occupational Transmission of Neisseria meningitidis — California, 2009. MMWR Morb Mortal Wkly Rep. November 19, 2010 59:1480-1483.
  25. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63:42-48.
  26. Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. J Infect. 2010;61:114-124.
  27. Misra UK, Kalita J. Seizures in encephalitis: predictors and outcome. Seizure. 2009;18:583-587.
  28. Curren EJ LJ, Kolsin J, et al. . West Nile Virus and Other Nationally Notifiable Arboviral Diseases – United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:1137-1142. DOI: https://www.cdc.gov/mmwr/volumes/1167/wr/mm6741a1131.htm?s_cid=mm6741a1131_w.
  29. Mehta R, Gerardin P, de Brito C, Soares C, Brito Ferreira M, Solomon T. The neurological complications of chikungunya virus: A systematic review. Rev Med Virol. 2018;28:e1978.
  30. Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis. 2009;49:942-948.
  31. Li GH, Ning ZJ, Liu YM, Li XH. Neurological Manifestations of Dengue Infection. Front Cell Infect Microbiol. 2017;7:449.
  32. Garcia G, Gonzalez N, Perez AB, et al. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis. 2011;15:e38-43.
  33. Sadek JR, Pergam SA, Harrington JA, et al. Persistent neuropsychological impairment associated with West Nile virus infection. J Clin Exp Neuropsychol. 2010;32:81-87.
  34. Madden K. West Nile virus infection and its neurological manifestations. Clin Med Res. 2003;1:145-150.
  35. Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect Dis Clin North Am. 2008;22:469-488, viii-ix.
  36. Bakken JS, Dumler JS. Human granulocytic anaplasmosis. Infect Dis Clin North Am. 2015;29:341-355.
  37. Shapiro ED. Clinical practice. Lyme disease. N Engl J Med. 2014;370:1724-1731.
  38. Touradji P, Aucott JN, Yang T, Rebman AW, Bechtold KT. Cognitive Decline in Post-treatment Lyme Disease Syndrome. Arch Clin Neuropsychol. 2019;34:455-465.
  39. Biggs HM, Behravesh D, Bradley KK, et al. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis — United States. A Practical Guide for Health Care and Public Health Professionals. MMWR Morb Mortal Wkly Rep. 2016;65.
  40. Bergeron JW, Braddom RL, Kaelin DL. Persisting impairment following Rocky Mountain Spotted Fever: a case report. Arch Phys Med Rehabil. 1997;78:1277-1280.
  41. Nemeth V, Pfleghaar N. Stat Pearls: Diarrhea. Treasure Island, Florida StatPearls Publishing; November 21, 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK448082/
  42. Centers for Disease Control and Prevention (CDC). Norovirus in Healthcare Facilities Fact Sheet. September 6, 2011. Available at: https://www.cdc.gov/hai/pdfs/norovirus/229110-ANoroCaseFactSheet508.pdf. .
  43. Palacio H, Shah U, Kilborn C, et al. Norovirus outbreak among evacuees from Hurricane Katrina – Houston, Texas, September 2005. MMWR Morb Mortal Wkly Rep. October 14, 2005;54:1016-1018.
  44. Barth WF, Segal K. Reactive arthritis (Reiter’s syndrome). Am Fam Physician. 1999;60:499-503, 507.
  45. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis. 2017;65:e45-e80.